4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lite Strategy, Inc. (LITS) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 4 employees. Its market capitalization is roughly $34 million. In the fiscal year ended 2025-06-30, LITS reported $0M in revenue and ($16M) in net income.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc.
Interactive charts & full statements →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | $0M | $65M | $49M | $41M |
| Gross Profit | — | — | — | $41M |
| Operating Income (EBIT) | ($18M) | $25M | ($37M) | ($76M) |
| Net Income | ($16M) | $18M | ($32M) | ($54M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | — | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($3M) | ($3M) | ($3M) | ($3M) | ($3M) | — |
| Net Income | ($24M) | ($31M) | ($4M) | ($3M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Dividends Paid | $0M | ($12M) | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | — | — | — | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | $18M | $41M | $121M | $178M |
| Total Liabilities | $1M | $8M | $96M | $125M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LITS viewer.
About TickerBase · Data methodology & sources